Bavarian Nordic wins positive CHMP opinion to amend Imvanex approval
The current approval, which is based on data from non-human primates and healthy individuals, will be updated with real-world observations.
Therapy Area
Cue Biopharma downsizes to focus on autoimmune pipeline
Mankind Pharma acquires Bharat Serums and Vaccines for $1.6bn
Ipsen outlines $461m for ex-US rights to Day One’s glioma therapy
Sandoz launches ustekinumab biosimilar in Europe
ConSynance wins FDA designation for Prader-Willi syndrome therapy
Dren Bio and Novartis link on bispecific antibodies for cancer
MHRA approves Pfizer-BioNTech’s Comirnaty JN.1 vaccine
